Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8BMB3

Entry ID Method Resolution Chain Position Source
AF-Q8BMB3-F1 Predicted AlphaFoldDB

12 variants for Q8BMB3

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3388483388 24 T>S No EVA
rs13464593 31 E>G No EVA
rs3388483699 71 R>P No EVA
rs3388484474 77 S>I No EVA
rs3388484532 77 S>R No EVA
rs3390274201 78 Y>* No EVA
rs3388483363 109 G>D No EVA
rs3388484993 129 N>K No EVA
rs3388483984 134 K>N No EVA
rs3388485762 138 R>G No EVA
rs3388483909 145 S>F No EVA
rs3388487119 211 I>F No EVA

No associated diseases with Q8BMB3

No regional properties for Q8BMB3

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q8BMB3

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Cytoplasm, P-body
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
eukaryotic translation initiation factor 4F complex The eukaryotic translation initiation factor 4F complex is composed of eIF4E, eIF4A and eIF4G; it is involved in the recognition of the mRNA cap, ATP-dependent unwinding of the 5'-terminal secondary structure and recruitment of the mRNA to the ribosome.
mRNA cap binding complex Any protein complex that binds to an mRNA cap at any time in the lifetime of the mRNA.
P-body A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing.

3 GO annotations of molecular function

Name Definition
RNA 7-methylguanosine cap binding Binding to a 7-methylguanosine group added cotranscriptionally to the 5' end of RNA molecules transcribed by polymerase II.
translation initiation factor activity Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.

3 GO annotations of biological process

Name Definition
in utero embryonic development The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
miRNA-mediated gene silencing by inhibition of translation An RNA interference pathway in which microRNAs (miRNAs) block the translation of target mRNAs into proteins. Once incorporated into a RNA-induced silencing complex (RISC), a miRNA will typically mediate repression of translation if the miRNA imperfectly base-pairs with the 3' untranslated regions of target mRNAs.
negative regulation of translation Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
A3RCV9 NCBP Eukaryotic translation initiation factor NCBP Triticum aestivum (Wheat) PR
O60573 EIF4E2 Eukaryotic translation initiation factor 4E type 2 Homo sapiens (Human) PR
P63073 Eif4e Eukaryotic translation initiation factor 4E Mus musculus (Mouse) PR
Q10NQ9 NCBP Eukaryotic translation initiation factor NCBP Oryza sativa subsp japonica (Rice) PR
Q22888 ife-4 Eukaryotic translation initiation factor 4E-4 Caenorhabditis elegans PR
10 20 30 40 50 60
MNNKFDALKD DDSGDHDQNE ENSTQKDGEK EKTDRDKSQS SGKRKAVVPG PAEHPLQYNY
70 80 90 100 110 120
TFWYSRRTPG RPTSSQSYEQ NIKQIGTFAS VEQFWKFYSH MVRPGDLTGH SDFHLFKEGI
130 140 150 160 170 180
KPMWEDDANK NGGKWIIRLR KGLASRCWEN LILAMLGEQF MVGEEICGAV VSVRFQEDII
190 200 210 220 230 240
SIWNKTASDQ ATTARIRDTL RRVLNLPPNT IMEYKTHTDS IKMPGRLGPQ RLLFQNLWKP
RLNVP